{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:10:44Z","timestamp":1778854244868,"version":"3.51.4"},"reference-count":75,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010905","name":"Illumina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015537","name":"The University of North Carolina at Chapel Hill Department of Pathology and Laboratory Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.pathol.2025.12.006","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T23:57:44Z","timestamp":1772841464000},"page":"399-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptomic classification and clinicopathologic correlation of hepatocellular neoplasms with steatotic features in non-cirrhotic livers"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9795-7890","authenticated-orcid":false,"given":"Lee-Ching","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8529-8293","authenticated-orcid":false,"given":"Sushant A.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peyton C.","family":"Kuhlers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse R.","family":"Raab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4924-1767","authenticated-orcid":false,"given":"Adam D.","family":"Pfefferle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0921-1368","authenticated-orcid":false,"given":"Michele C.","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Wielgus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6019-5853","authenticated-orcid":false,"given":"Gabriela E.","family":"De la Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surekha","family":"Bantumilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1216-477X","authenticated-orcid":false,"given":"Katherine A.","family":"Hoadley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0865-3394","authenticated-orcid":false,"given":"Jason D.","family":"Merker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2025.12.006_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: Cancer J Clin"},{"key":"10.1016\/j.pathol.2025.12.006_bib2","first-page":"203","article-title":"Cancer statistics, 2024. CA: cancer J Clin. 2024;74:12\u201349","volume":"74","author":"Siegel","year":"2024","journal-title":"Erratum CA: Cancer J Clin"},{"key":"10.1016\/j.pathol.2025.12.006_bib3","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pathol.2025.12.006_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.pathol.2025.12.006_bib5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.pathol.2025.12.006_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.aohep.2019.07.004","article-title":"Obesity and liver cancer","volume":"18","author":"Saitta","year":"2019","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.pathol.2025.12.006_bib7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7150\/ijbs.29599","article-title":"Obesity, Nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer","volume":"15","author":"Divella","year":"2019","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.pathol.2025.12.006_bib8","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.pathol.2025.12.006_bib9","series-title":"Digestive system tumours, WHO classification of tumours Editorial board","first-page":"229","article-title":"Hepatocellular carcinoma","author":"Torbenson","year":"2019"},{"key":"10.1016\/j.pathol.2025.12.006_bib10","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/PAS.0b013e3181f31caa","article-title":"Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD\/NASH","volume":"34","author":"Salomao","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2025.12.006_bib11","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.humpath.2015.07.018","article-title":"Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study","volume":"46","author":"Yeh","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2025.12.006_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2174\/1566524033479546","article-title":"Mechanisms of human hepatocarcinogenesis","volume":"3","author":"Coleman","year":"2003","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.pathol.2025.12.006_bib13","doi-asserted-by":"crossref","first-page":"E9879","DOI":"10.1073\/pnas.1811029115","article-title":"Integrative genomic analysis of mouse and human hepatocellular carcinoma","volume":"115","author":"Dow","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2025.12.006_bib14","doi-asserted-by":"crossref","unstructured":"Yim SY, Lee JS. An overview of the genomic characterization of hepatocellular carcinoma. J Hepatocell Carcinoma. 20217;8:1077\u20131088.","DOI":"10.2147\/JHC.S270533"},{"key":"10.1016\/j.pathol.2025.12.006_bib15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/modpathol.3800998","article-title":"Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions","volume":"21","author":"Skawran","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2025.12.006_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911923","article-title":"Spontaneous occurrence of various types of hepatocellular adenoma in the livers of metabolic syndrome-associated steatohepatitis model TSOD mice","volume":"23","author":"Shao","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pathol.2025.12.006_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2559.2010.03554.x","article-title":"Genomic and immunophenotypical differences between hepatocellular carcinoma with and without cirrhosis","volume":"56","author":"Tretiakova","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2025.12.006_bib18","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.3390\/cancers12082265","article-title":"Genetically engineered mouse models of liver tumorigenesis reveal a wide histological spectrum of neoplastic and non-neoplastic liver lesions","volume":"12","author":"Steiger","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pathol.2025.12.006_bib19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41575-018-0033-6","article-title":"Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research","volume":"15","author":"Brown","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.pathol.2025.12.006_bib20","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jhep.2008.02.001","article-title":"Human and mouse hepatocellular adenoma and carcinoma display similar tumorigenesis pathway alterations","volume":"48","author":"Zucman-Rossi","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.pathol.2025.12.006_bib21","series-title":"Hepatocellular carcinoma [Internet]","article-title":"Mouse models of hepatocellular carcinoma","author":"Carlessi","year":"2019"},{"key":"10.1016\/j.pathol.2025.12.006_bib22","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1038\/sj.onc.1209547","article-title":"Genetics of hepatocellular tumors","volume":"25","author":"Laurent-Puig","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2025.12.006_bib23","article-title":"Molecular pathology of hepatic neoplasms: classification and clinical significance","volume":"2011","author":"Walther","year":"2011","journal-title":"Patholog Res Int"},{"key":"10.1016\/j.pathol.2025.12.006_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12943-017-0712-x","article-title":"The biology of hepatocellular carcinoma: implications for genomic and immune therapies","volume":"16","author":"Khemlina","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.pathol.2025.12.006_bib25","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-019-1670-9","article-title":"Somatic mutations and clonal dynamics in healthy and cirrhotic human liver","volume":"574","author":"Brunner","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2025.12.006_bib26","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jhep.2020.01.019","article-title":"The landscape of gene mutations in cirrhosis and hepatocellular carcinoma","volume":"72","author":"M\u00fcller","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.pathol.2025.12.006_bib27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.dld.2009.09.002","article-title":"Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal","volume":"42","author":"Trevisani","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.pathol.2025.12.006_bib28","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pathol.2025.12.006_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.pathol.2025.12.006_bib30","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.3748\/wjg.v27.i24.3466","article-title":"Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: current insights and advancements","volume":"27","author":"Perisetti","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pathol.2025.12.006_bib31","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1478-3231.2012.02786.x","article-title":"Hepatocellular adenoma subtypes: the impact of overweight and obesity","volume":"32","author":"Bioulac-Sage","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.pathol.2025.12.006_bib32","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41575-022-00643-5","article-title":"Benign liver tumours: understanding molecular physiology to adapt clinical management","volume":"19","author":"Nault","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.pathol.2025.12.006_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/j.gastro.2019.02.049","article-title":"Surveillance for hepatocellular carcinoma: current best practice and future direction","volume":"157","author":"Kanwal","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pathol.2025.12.006_bib34","article-title":"Are hepatocellular neoplasms with a Cytokeratin 7-positive pseudoglandular pattern destined for malignant transformation? A comparison of two cases","volume":"27","author":"Lilly","year":"2022","journal-title":"Hum Pathol Rep"},{"key":"10.1016\/j.pathol.2025.12.006_bib35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2217\/hep.14.14","article-title":"Malignant transformation of hepatocellular adenoma","volume":"1","author":"Sempoux","year":"2014","journal-title":"Hepat Oncol"},{"key":"10.1016\/j.pathol.2025.12.006_bib36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1477-2574.2010.00222.x","article-title":"Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases","volume":"12","author":"Stoot","year":"2010","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.pathol.2025.12.006_bib37","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1053\/j.gastro.2016.11.042","article-title":"Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation","volume":"152","author":"Nault","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pathol.2025.12.006_bib38","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41379-019-0374-x","article-title":"Transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon","volume":"33","author":"Putra","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2025.12.006_bib39","article-title":"Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas","volume":"3","author":"Chopinet","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.pathol.2025.12.006_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2018.08.004","article-title":"Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA","volume":"83","author":"Hechtman","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2025.12.006_bib41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.humpath.2013.09.020","article-title":"Well-differentiated hepatocellular neoplasm of uncertain malignant potential: proposal for a new diagnostic category","volume":"45","author":"Bedossa","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2025.12.006_bib42","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/PAP.0000000000000189","article-title":"Atypical hepatocellular neoplasms: review of clinical, morphologic, immunohistochemical, molecular, and cytogenetic features","volume":"25","author":"Choi","year":"2018","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.pathol.2025.12.006_bib43","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0002-9440(10)63893-X","article-title":"cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis","volume":"162","author":"Anders","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2025.12.006_bib44","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/modpathol.2014.50","article-title":"Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor","volume":"27","author":"Kakar","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2025.12.006_bib45","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/s41379-019-0282-0","article-title":"Genomic profiling of well-differentiated hepatocellular neoplasms with diffuse glutamine synthetase staining reveals similar genetics across the adenoma to carcinoma spectrum","volume":"32","author":"Joseph","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2025.12.006_bib46","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.humpath.2022.01.007","article-title":"Hepatocellular neoplasms with loss of liver fatty acid binding protein: clinicopathologic features and molecular profiling","volume":"122","author":"Joseph","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2025.12.006_bib47","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/his.14858","article-title":"Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features","volume":"82","author":"Haefliger","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2025.12.006_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100211","article-title":"Borderline hepatocellular adenomas: a practical diagnostic approach based on pathologic and molecular features","volume":"36","author":"Pot\u00e9","year":"2023","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2025.12.006_bib49","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1097\/01.pas.0000176426.21876.a5","article-title":"Identification of a unique gene expression signature that differentiates hepatocellular adenoma from well-differentiated hepatocellular carcinoma","volume":"29","author":"Chen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2025.12.006_bib50","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/modpathol.3800998","article-title":"Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions","volume":"21","author":"Skawran","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2025.12.006_bib51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.pathol.2025.12.006_bib52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.pathol.2025.12.006_bib53","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.pathol.2025.12.006_bib54","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/s12859-021-04461-5","article-title":"GeneTonic: an R\/Bioconductor package for streamlining the interpretation of RNA-seq data","volume":"22","author":"Marini","year":"2021","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.pathol.2025.12.006_bib56","doi-asserted-by":"crossref","DOI":"10.2217\/hep-2017-0023","article-title":"Molecular classification of hepatocellular adenomas: impact on clinical practice","volume":"5","author":"V\u00e9die","year":"2018","journal-title":"Hepat Oncol"},{"key":"10.1016\/j.pathol.2025.12.006_bib57","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2013.09.020","article-title":"\u03b2-Catenin signaling in hepatocellular cancer: implications in inflammation, fibrosis, and proliferation","volume":"343","author":"Lee","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pathol.2025.12.006_bib58","first-page":"45477","article-title":"Predictive patterns of glutamine synthetase immunohistochemical staining in CTNNB1-mutated hepatocellular adenomas","author":"Sempoux","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2025.12.006_bib59","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0022-3476(98)70070-8","article-title":"Transient neonatal cholestasis: origin and outcome","volume":"133","author":"Jacquemin","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.pathol.2025.12.006_bib60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000514174","article-title":"Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update","volume":"10","author":"Kudo","year":"2021","journal-title":"Liver Cancer"},{"key":"10.1016\/j.pathol.2025.12.006_bib61","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","article-title":"Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"23","author":"Tan","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pathol.2025.12.006_bib62","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0968-0004(87)90092-2","article-title":"The cystatins: a new class of peptidase inhibitors","volume":"12","author":"Barrett","year":"1987","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.pathol.2025.12.006_bib63","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.2741\/3089","article-title":"Cystatins: biochemical and structural properties, and medical relevance","volume":"13","author":"Turk","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.pathol.2025.12.006_bib64","doi-asserted-by":"crossref","first-page":"22623","DOI":"10.1002\/jcp.28828","article-title":"Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis","volume":"234","author":"Cui","year":"2019","journal-title":"J Cell Phys"},{"key":"10.1016\/j.pathol.2025.12.006_bib65","first-page":"189","article-title":"Investigation of the clinical significance and prospective molecular mechanisms of cystatin genes in patients with hepatitis B virus-related hepatocellular carcinoma","volume":"42","author":"Zhou","year":"2019","journal-title":"Oncol Rep"},{"key":"10.1016\/j.pathol.2025.12.006_bib66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.gene.2005.07.005","article-title":"Structural organization of the human complexin 2 gene (CPLX2) and aspects of its functional activity","volume":"359","author":"Raevskaya","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.pathol.2025.12.006_bib67","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1523\/JNEUROSCI.2703-14.2015","article-title":"Functional roles of complexin in neurotransmitter release at ribbon synapses of mouse retinal bipolar neurons","volume":"35","author":"Vaithianathan","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.pathol.2025.12.006_bib68","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/iid3.276","article-title":"Complexin 2 regulates secretion of immunoglobulin in antibody-secreting cells","volume":"7","author":"Tsuru","year":"2019","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.pathol.2025.12.006_bib69","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s12010-022-04135-9","article-title":"CPLX2 regulates ferroptosis and apoptosis through NRF2 pathway in human hepatocellular carcinoma cells","volume":"195","author":"Li","year":"2023","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.pathol.2025.12.006_bib70","first-page":"984","article-title":"Gender differences in the pathogenesis and risk factors of hepatocellular carcinoma","volume":"12","author":"Nevola","year":"2023","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.pathol.2025.12.006_bib71","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2017.09.016","article-title":"Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine","volume":"68","author":"Fujiwara","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.pathol.2025.12.006_bib72","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.3390\/jcm9123817","article-title":"Risk factors, pathogenesis, and strategies for hepatocellular carcinoma prevention: emphasis on secondary prevention and its translational challenges","volume":"9","author":"Li","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.pathol.2025.12.006_bib73","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/liv.13423","article-title":"Men with biopsy-confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: a nationwide population-based study","volume":"37","author":"Bossen","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.pathol.2025.12.006_bib74","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1477-2574.2010.00222.x","article-title":"Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases","volume":"12","author":"Stoot","year":"2010","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.pathol.2025.12.006_bib75","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.21068","article-title":"Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC","volume":"43","author":"Zucman-Rossi","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.pathol.2025.12.006_bib76","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.14309\/ajg.0000000000002857","article-title":"ACG clinical guideline: focal liver lesions","volume":"119","author":"Frenette","year":"2024","journal-title":"Am J Gastroenterol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302526004320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302526004320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:37:42Z","timestamp":1778852262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302526004320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0031302526004320"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2025.12.006","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptomic classification and clinicopathologic correlation of hepatocellular neoplasms with steatotic features in non-cirrhotic livers","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2025.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}